
Braveheart Bio (NasdaqGM: BRVE) completed its IPO and listed on the Nasdaq Global Market, with trading commencing before 11 August 2026. The company was added to the NASDAQ Composite Index shortly after the IPO, bringing the stock into a broad market benchmark. Following the listing and index inclusion, Braveheart Bio filed a large shelf registration to provide flexibility for future capital raises. This kind of rapid move from IPO to index inclusion has drawn attention to founder-led...




